Cargando…
Epitope Selection for Fighting Visceral Leishmaniosis: Not All Peptides Function the Same Way
Visceral leishmaniosis (VL) caused by Leishmania infantum is a disease with an increasing prevalence worldwide. Treatments are expensive, toxic, and ineffective. Therefore, vaccination seems to be a promising approach to control VL. Peptide-based vaccination is a useful method due to its stability,...
Autores principales: | Martínez-Rodrigo, Abel, Mas, Alicia, Álvarez-Campos, Daniel, Orden, José A., Domínguez-Bernal, Gustavo, Carrión, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564088/ https://www.ncbi.nlm.nih.gov/pubmed/32630347 http://dx.doi.org/10.3390/vaccines8030352 |
Ejemplares similares
-
Mechanisms of resistance and susceptibility to experimental visceral leishmaniosis: BALB/c mouse versus syrian hamster model
por: Nieto, Ana, et al.
Publicado: (2011) -
HisAK70: progress towards a vaccine against different forms of leishmaniosis
por: Domínguez-Bernal, Gustavo, et al.
Publicado: (2015) -
Characterisation of the ex vivo virulence of Leishmania infantum isolates from Phlebotomus perniciosus from an outbreak of human leishmaniosis in Madrid, Spain
por: Domínguez-Bernal, Gustavo, et al.
Publicado: (2014) -
UCP2 Deficiency Helps to Restrict the Pathogenesis of Experimental Cutaneous and Visceral Leishmaniosis in Mice
por: Carrión, Javier, et al.
Publicado: (2013) -
Mitigating an undesirable immune response of inherent susceptibility to cutaneous leishmaniosis in a mouse model: the role of the pathoantigenic HISA70 DNA vaccine
por: Domínguez-Bernal, Gustavo, et al.
Publicado: (2012)